Aston Jeff, Wilson Keith A, Terry David R P
Pharmacy Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
School of Life and Health Sciences, Aston University, Birmingham, UK.
Int J Pharm Pract. 2018 Apr;26(2):104-110. doi: 10.1111/ijpp.12371. Epub 2017 Apr 3.
To determine whether community pharmacists undertake medication reviews with children/their carers and to identify the type of medication-related experiences presented to them when a child is taking long-term medication.
A 13 question semi-structured survey was posted to 354 England-based community pharmacists with telephone follow-up/repeat mailing of non-responders. Participants were asked about their practice as a community pharmacist over the preceding 12 months to children/young people, or their carers, taking long-term medication. The questionnaire covered: medication review, reported adherence, information requests, adverse effects, administration and obtaining medication supplies. The data were analysed using SPSS version 22 and NVivo version 10.
The response rate was 76/354 (21.5%). Eighteen (23.7%) respondents had undertaken a Medicines Use Review (MUR) and 22 (28.9%) a New Medicines Service (NMS) medication review with a child/their carer. Participants reported that patients/their carers had presented to them with non-adherence including stopping medication (24, 31.6%) and changing the dose (28, 36.8%). Respondents were directly asked about the indication (59, 77.6%), dose regimen (63, 82.9%), administration (64, 84.2%) and adverse effects (58, 76.3%) of prescribed medication. Respondents reported patients/carers experiencing difficulties obtaining medication from their community pharmacy (47, 61.8%) and patients' family doctors declining to prescribe a medication recommended by a specialist (27, 35.5%).
Medicines Use Review and NMS reviews are utilised by community pharmacists in children/their carers. The medication-related experiences presenting to community pharmacists could fall within the purview of a medication review (MUR or NMS). There is scope to further extend this service to this group of patients/carers.
确定社区药剂师是否会与儿童/其照顾者进行用药评估，并识别儿童长期服药时向他们反馈的与用药相关的经历类型。
向354名英格兰社区药剂师发放了一份包含13个问题的半结构式调查问卷，并对未回复者进行电话随访/再次邮寄问卷。参与者被问及他们在过去12个月作为社区药剂师对服用长期药物的儿童/年轻人或其照顾者的工作情况。问卷涵盖：用药评估、报告的依从性、信息询问、不良反应、给药及获取药品供应。使用SPSS 22版和NVivo 10版软件对数据进行分析。
回复率为76/354（21.5%）。18名（23.7%）受访者对儿童/其照顾者进行过药物使用评估（MUR），22名（28.9%）进行过新药物服务（NMS）用药评估。参与者报告称，患者/其照顾者向他们反馈了不依从情况，包括停药（24例，31.6%）和改变剂量（28例，36.8%）。直接询问了受访者关于处方药的适应证（59例，77.6%）、给药方案（63例，82.9%）、给药方式（64例，84.2%）和不良反应（58例，76.3%）。受访者报告称，患者/照顾者在社区药房获取药品时遇到困难（47例，61.8%），且患者的家庭医生拒绝开具专科医生推荐的药物（27例，35.5%）。
社区药剂师会对儿童/其照顾者开展药物使用评估和新药物服务评估。社区药剂师所接触到的与用药相关的经历可能属于用药评估（MUR或NMS）的范畴。有进一步将这项服务扩展至这类患者/照顾者的空间。
